A Study of LY3127804 in Participants With COVID-19
Status:
Terminated
Trial end date:
2020-10-12
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo-controlled, clinical trial of LY3127804 in participants
who are hospitalized with pneumonia and presumed or confirmed COVID-19.